These innovative medications, which mimic the action of naturally occurring hormones in the body, have shown remarkable results in suppressing appetite and promoting weight loss
12 , e0175437 (2017)
The demand for medically supervised weight loss using GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro has increased dramatically in recent months
But this might soon change
The global sales of the drug in H1 2023 has reached USD 1,548.2 million 1&2
We find that patients benefit from at least a 12-month comprehensive weight-loss program to establish the proper habits to sustain long-term weight loss If you are not a good candidate for GLP-1 agonists, our physicians will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools that we use as a part of our weight loss program in Laredo, Texas